EXPRESSION OF THE FUNCTIONAL SOLUBLE FORM OF HUMAN FAS LIGAND IN ACTIVATED LYMPHOCYTES

被引:609
作者
TANAKA, M
SUDA, T
TAKAHASHI, T
NAGATA, S
机构
[1] Osaka Bioscience Institute, Suita, Osaka 565
关键词
APOPTOSIS; CYTOKINE; CYTOTOXICITY; FAS; FAS LIGAND;
D O I
10.1002/j.1460-2075.1995.tb07096.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fas is a type I membrane protein which mediates apoptosis. Fas ligand (FasL) is a 40 kDa type II membrane protein expressed in cytotoxic T cells upon activation that belongs to the tumor necrosis factor (TNF) family. Here, we found abundant cytotoxic activity against Fas-expressing cells in the supernatant of COS cells transfected with human FasL cDNA but not with murine FasL cDNA. Using a specific polyclonal antibody against a peptide in the extracellular region of human FasL, a protein of 26 kDa was detected in the supernatant of the COS cells. The signal sequence of granulocyte colony-stimulating factor was attached to the extracellular region of human FasL. COS cells transfected with the cDNA coding for the chimeric protein efficiently secreted the active soluble form of human FasL (sFasL). Chemical crosslinking and gel filtration analysis suggested that human sFasL exists as a trimer. Human peripheral T cells activated with phorbol myristic acetate and ionomycin also produced functional sFasL, suggesting that human sFasL works as a pathological agent in systemic tissue injury.
引用
收藏
页码:1129 / 1135
页数:7
相关论文
共 55 条
[21]   ANTI-FAS MONOCLONAL-ANTIBODY IS CYTOCIDAL TO HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CELLS WITHOUT AUGMENTING VIRAL REPLICATION [J].
KOBAYASHI, N ;
HAMAMOTO, Y ;
YAMAMOTO, N ;
ISHII, A ;
YONEHARA, M ;
YONEHARA, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (24) :9620-9624
[22]   2 DISTINCT PATHWAYS OF SPECIFIC KILLING REVEALED BY PERFORIN MUTANT CYTOTOXIC T-LYMPHOCYTES [J].
KOJIMA, H ;
SHINOHARA, N ;
HANAOKA, S ;
SOMEYASHIROTA, Y ;
TAKAGAKI, Y ;
OHNO, H ;
SAITO, T ;
KATAYAMA, T ;
YAGITA, H ;
OKUMURA, K ;
SHINKAI, Y ;
ALT, FW ;
MATSUZAWA, A ;
YONEHARA, S ;
TAKAYAMA, H .
IMMUNITY, 1994, 1 (05) :357-364
[23]   A NOVEL FORM OF TNF/CACHECTIN IS A CELL-SURFACE CYTO-TOXIC TRANSMEMBRANE PROTEIN - RAMIFICATIONS FOR THE COMPLEX PHYSIOLOGY OF TNF [J].
KRIEGLER, M ;
PEREZ, C ;
DEFAY, K ;
ALBERT, I ;
LU, SD .
CELL, 1988, 53 (01) :45-53
[24]  
LEITHAUSER F, 1993, LAB INVEST, V69, P415
[25]   CYTOLYTIC T-CELL CYTOTOXICITY IS MEDIATED THROUGH PERFORIN AND FAS LYTIC PATHWAYS [J].
LOWIN, B ;
HAHNE, M ;
MATTMANN, C ;
TSCHOPP, J .
NATURE, 1994, 370 (6491) :650-652
[26]   REGULATION OF TUMOR-NECROSIS-FACTOR-ALPHA PROCESSING BY A METALLOPROTEINASE INHIBITOR [J].
MCGEEHAN, GM ;
BECHERER, JD ;
BAST, RC ;
BOYER, CM ;
CHAMPION, B ;
CONNOLLY, KM ;
CONWAY, JG ;
FURDON, P ;
KARP, S ;
KIDAO, S ;
MCELROY, AB ;
NICHOLS, J ;
PRYZWANSKY, KM ;
SCHOENEN, F ;
SEKUT, L ;
TRUESDALE, A ;
VERGHESE, M ;
WARNER, J ;
WAYS, JP .
NATURE, 1994, 370 (6490) :558-561
[27]   PEF-BOS, A POWERFUL MAMMALIAN EXPRESSION VECTOR [J].
MIZUSHIMA, S ;
NAGATA, S .
NUCLEIC ACIDS RESEARCH, 1990, 18 (17) :5322-5322
[28]   PROTECTION AGAINST A LETHAL DOSE OF ENDOTOXIN BY AN INHIBITOR OF TUMOR-NECROSIS-FACTOR PROCESSING [J].
MOHLER, KM ;
SLEATH, PR ;
FITZNER, JN ;
CERRETTI, DP ;
ALDERSON, M ;
KERWAR, SS ;
TORRANCE, DS ;
OTTENEVANS, C ;
GREENSTREET, T ;
WEERAWARNA, K ;
KRONHEIM, SR ;
PETERSEN, M ;
GERHART, M ;
KOZLOSKY, CJ ;
MARCH, CJ ;
BLACK, RA .
NATURE, 1994, 370 (6486) :218-220
[29]   FAS AND FAS LIGAND - LPR AND GLD MUTATIONS [J].
NAGATA, S ;
SUDA, T .
IMMUNOLOGY TODAY, 1995, 16 (01) :39-43
[30]   FAS AND FAS LIGAND - A DEATH FACTOR AND ITS RECEPTOR [J].
NAGATA, S .
ADVANCES IN IMMUNOLOGY, VOL 57, 1994, 57 :129-144